Keywords: exelixis, signs, 80m, accord, b-ms, drugmakers, bristol-myers

Exelixis signs $80M R&D accord with B-MS

Article | 22 December 2006

US drugmakers Exelixis and Bristol-Myers Squibb have entered into a worldwide collaboration to discover, develop and commercialize novel targeted therapies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Drug Discovery

Go to company listing